Dashboard PDUFA PDUFA History Dilution Watch Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track CRNX with free AI briefings, catalyst countdowns, and dilution alerts.
Start 7-day free trial → Log in

CRNX · Crinetics Pharmaceuticals, Inc.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

Acquired. Crinetics Pharmaceuticals was acquired: the merger closed on Sep 1, 2026 and CRNX was delisted. The data below is from before the deal. Read the filing
Follow CRNX by email Get an email when CRNX pushes back a promised milestone, files for a stock offering or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about CRNX, unsubscribe in one click. Privacy

📅 Past FDA Decisions & Stock Reactions

DateDrugTypeRun-up 30dDecision 1dAfter 5d
2025-09-25 — NDA +16.9% +2% +18.3%

Browse all historical PDUFA outcomes →

Get the full CRNX picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for CRNX and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.